The Hawaii State Department of Health today released its December 2017 newsletter, Medical Cannabis Update. In the one-page newsletter, the department reports that a third private laboratory is scheduled to submit its pesticide validation studies and an onsite laboratory inspection, and DOH announced that it has added ALS to its list of qualifying conditions for medical cannabis patients. DOH rejected the petition to add General Anxiety Disorder (GAD) as a qualifying condition stating, “there is inconclusive medical evidence that cannabis has beneficial use in the treatment or alleviation of symptoms of anxiety, social phobia, and Social Anxiety Disorder (SAD), and no evidence specific to GAD.”
It is the Alliance’s mission to provide up-to-date and relevant industry information to the patients, current and future dispensaries, and related businesses of Hawai‘i’s growing medicinal cannabis industry. If you are not yet a member of the Hawai‘i Dispensary Alliance, join today to receive Cannabis Insider bi-monthly, and take an active role in the future of Hawai‘i’s medical marijuana industry. Contact us today and we will send you the Cannabis Insider November/December 2017 edition absolutely free. You can also find us on Facebook or Twitter. Raise your voice, take action, and join the Hawai‘i Dispensary Alliance today.